Breaking news on life science and diagnostics business, policy, and funding
The Finnish firm will use the funds to commercialize its Novodiag molecular diagnostics system.
Nashville Biosciences will offer access to BioVU, Vanderbilt University Medical Center's collection of DNA samples and patient records, through BC Platforms' solution.
At the Personalized Medicine Conference this week, stakeholders historically at odds over lab test regulation said it is up to Congress to resolve the issue.
The infringement relates to US patents held by the University of Chicago and exclusively licensed to Bio-Rad.
The firm announced in October that had entered into an agreement with Jefferies to sell up to $50 million in shares from time to time.
Though many details have yet to be worked out, the draft deal for the UK's withdrawal from the EU is giving researchers some hints for what they can expect, Nature News says.
DNA testing has solved a 100-year-old mystery contained in the skull and teeth samples of a now-extinct monkey that once inhabited Jamaica, Gizmodo reports.
As the UN ponders a ban on gene drives, one malaria researcher says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.
In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.